Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ALNY | ALNYLAM PHARMACEUTICALS, INC. | EVP, Chief Commercial Officer | $3.27M | -$598K | -15.5% | Jun 24, 2024 |
LXEO | Lexeo Therapeutics, Inc. | Director | Nov 11, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|